Predictive Study of Serum Endocan for Hemorrhagic Transformation After Reperfusion Therapies in Acute Ischemic Stroke
NCT05228080
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Acute Ischemic Stroke
Interventions
DIAGNOSTIC_TEST:
enzyme-linked immunosorbent assay(ELISA)
Sponsor
Xijing Hospital